Clinical Trial Update: Study to Evaluate Efficacy and Safety of Inclisiran in Adolescents With Heterozygous Familial Hypercholesterolemia [Phase 3]

View source ↗

Summary

A Phase 3 trial assessing the efficacy and safety of inclisiran in adolescents with heterozygous familial hypercholesterolemia has completed. Results have been …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Hypercholesterolemia Heterozygous

Drugs mentioned

• LEQVIO (inclisiran)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Familial Hypercholesterolemia - Heterozygous | Phase 3 | Status: COMPLETED | Results posted: 2025-06-10